You may also like
Outcomes of Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome due to COVID-19: The Lessons Learned from the First Wave of COVID-19
Extracorporeal membrane oxygenation (ECMO) has been used as a refractory treatment for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19), but there has been little evidence of its efficacy. We conducted this study to share our experience using ECMO as a bridge to recovery for ARDS due to COVID-19.
1 min read
Time to Hang up Your Pump? What to do in the Absence of Definitive Evidence (EP Video)
Dolald Likosky what perfusionists should do when there in no clear supporting clinical evidence (35:14 minutes).
1 min read
Fiberoptic Monitoring of Central Venous Oxygen Saturation (PediaSat) in Small Children Undergoing Cardiac Surgery: Continuous is not Continuous
The objective of our study was to evaluate the correlation between continuous ScvO 2 by the application of a fiber-optic oximetry catheter (PediaSat) and intermittent ScvO 2 by using standard blood gas measurements.
1 min read